Madrigal Pharmaceuticals
MDGL
MDGL
222 hedge funds and large institutions have $3.36B invested in Madrigal Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 77 increasing their positions, 54 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
1.51% less ownership
Funds ownership: 77.95% → 76.45% (-1.5%)
13% less capital invested
Capital invested by funds: $3.86B → $3.36B (-$498M)
Holders
222
Holding in Top 10
10
Calls
$385M
Puts
$149M
Top Buyers
| 1 | +$131M | |
| 2 | +$95M | |
| 3 | +$46.8M | |
| 4 |
Renaissance Technologies
New York
|
+$41.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.8M |
Top Sellers
| 1 | -$180M | |
| 2 | -$125M | |
| 3 | -$38.7M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$33.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$31.1M |